Fore Biotherapeutics
Registry sponsor category
Industry
- Other names
- Fore Biotherapeutics
- Company name
- Fore Biotherapeutics
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (9)
- A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
- A Study of the Effects of Food and Cobicistat on Plixorafenib Pharmacokinetics in Healthy Participants.
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma
- Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
- NovellusDx Cancer Early Detection Blood Test- Clinical Trial
- NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients
- NovellusDx Tissue Collection Protocol
- Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.